PL1611106T3 - Wytwarzanie chlorowodorku chinaprylu - Google Patents

Wytwarzanie chlorowodorku chinaprylu

Info

Publication number
PL1611106T3
PL1611106T3 PL04721968T PL04721968T PL1611106T3 PL 1611106 T3 PL1611106 T3 PL 1611106T3 PL 04721968 T PL04721968 T PL 04721968T PL 04721968 T PL04721968 T PL 04721968T PL 1611106 T3 PL1611106 T3 PL 1611106T3
Authority
PL
Poland
Prior art keywords
preparation
quinapril hydrochloride
quinapril
hydrochloride
Prior art date
Application number
PL04721968T
Other languages
English (en)
Inventor
Sandra Marie Jennings
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of PL1611106T3 publication Critical patent/PL1611106T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL04721968T 2003-03-31 2004-03-19 Wytwarzanie chlorowodorku chinaprylu PL1611106T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45901603P 2003-03-31 2003-03-31
PCT/IB2004/000942 WO2004087671A1 (en) 2003-03-31 2004-03-19 Preparation of quinapril hydrochloride
EP04721968A EP1611106B1 (en) 2003-03-31 2004-03-19 Preparation of quinapril hydrochloride

Publications (1)

Publication Number Publication Date
PL1611106T3 true PL1611106T3 (pl) 2007-01-31

Family

ID=33131855

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04721968T PL1611106T3 (pl) 2003-03-31 2004-03-19 Wytwarzanie chlorowodorku chinaprylu

Country Status (22)

Country Link
US (1) US6858735B2 (pl)
EP (1) EP1611106B1 (pl)
JP (1) JP2006522092A (pl)
KR (1) KR20050115323A (pl)
CN (1) CN1747935A (pl)
AR (1) AR043949A1 (pl)
AT (1) ATE340161T1 (pl)
AU (1) AU2004226154B2 (pl)
BR (1) BRPI0408924A (pl)
CA (1) CA2517451C (pl)
CL (1) CL2004000541A1 (pl)
DE (1) DE602004002473T2 (pl)
DK (1) DK1611106T3 (pl)
ES (1) ES2271868T3 (pl)
MX (1) MXPA05010498A (pl)
PL (1) PL1611106T3 (pl)
PT (1) PT1611106E (pl)
RS (1) RS20050597A (pl)
RU (1) RU2298004C2 (pl)
TW (1) TWI284637B (pl)
WO (1) WO2004087671A1 (pl)
ZA (1) ZA200505214B (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009053994A1 (en) * 2007-10-26 2009-04-30 Matrix Laboratories Limited Process for preparing pure amorphous quinapril hydrochloride
JP6215339B2 (ja) 2012-11-12 2017-10-18 デピュイ・シンセス・プロダクツ・インコーポレイテッド 椎体間干渉インプラント及び器具

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4344949A (en) * 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
EP0065301A1 (en) 1981-05-18 1982-11-24 Merck & Co. Inc. Isoquinoline carboxylic acid derivates, process for preparing and pharmaceutical composition containing the same
US4686295A (en) * 1982-03-10 1987-08-11 Usv Pharmaceutical Corporation N-carboxy anhydride intermediates
US4761479A (en) * 1987-03-30 1988-08-02 Warner-Lambert Company Crystalline quinapril and a process for producing the same
ES2122941B1 (es) 1997-05-29 1999-07-01 Esteve Quimica Sa Procedimiento para la obtencion de quinapril clorhidrato y solvatos utiles para el aislamiento y purificacion de quinapril clorhidrato.
WO2002018321A2 (en) * 2000-08-29 2002-03-07 Abbott Laboratories Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
US6541635B1 (en) * 2002-03-29 2003-04-01 Everlight Usa, Inc. Method for producing angiotensin converting enzyme inhibitor
AU2002361494A1 (en) * 2002-12-16 2004-07-09 Lupin Limited Crystalline form of quinapril hydrochloride and process for preparing the same

Also Published As

Publication number Publication date
ATE340161T1 (de) 2006-10-15
DK1611106T3 (da) 2006-12-27
AR043949A1 (es) 2005-08-17
ZA200505214B (en) 2008-08-27
KR20050115323A (ko) 2005-12-07
PT1611106E (pt) 2006-11-30
TWI284637B (en) 2007-08-01
JP2006522092A (ja) 2006-09-28
ES2271868T3 (es) 2007-04-16
CN1747935A (zh) 2006-03-15
MXPA05010498A (es) 2005-11-16
AU2004226154A1 (en) 2004-10-14
CA2517451A1 (en) 2004-10-14
CL2004000541A1 (es) 2005-02-04
WO2004087671A1 (en) 2004-10-14
US6858735B2 (en) 2005-02-22
AU2004226154B2 (en) 2007-03-08
TW200424177A (en) 2004-11-16
RS20050597A (sr) 2007-09-21
DE602004002473T2 (de) 2007-06-14
EP1611106A1 (en) 2006-01-04
BRPI0408924A (pt) 2006-04-04
DE602004002473D1 (de) 2006-11-02
US20040192613A1 (en) 2004-09-30
CA2517451C (en) 2009-04-21
EP1611106B1 (en) 2006-09-20
RU2298004C2 (ru) 2007-04-27
RU2005130402A (ru) 2006-02-10

Similar Documents

Publication Publication Date Title
ZA200605348B (en) Solid forms of anti-EGFR-antibodies
PL378576A1 (pl) Wytwarzanie podstawionych chinazolin
EP1745573A4 (en) PROCESS FOR PREPARING 2-DEOXY-BETA-L-NUCLEOSIDES
PL1802579T3 (pl) Pochodne 3-aryloaminopirydynowe
EP1785131A4 (en) EXTERNAL PREPARATION OF TYPE S / O
GB0421149D0 (en) Preparation of oxycodone
IL172206A0 (en) Solid preparation
IL179558A0 (en) Irinotecan preparation
TWI339662B (en) Arylvinylazacycloalkane compounds and methods of preparation and use thereof
EP1595526A4 (en) PREPARATION OF CAPILLARY COLOR
PL1740204T3 (pl) Lecznicze zastosowanie alfa-mannozydazy
IL179331A0 (en) Preparation of levalbuterol hydrochloride
AU2003298725A8 (en) Preparation of metallotexaphyrins
ZA200505214B (en) Preparation of quinapril hydrochloride
GB0327742D0 (en) Novel uses of known drugs
SI1611106T1 (sl) Priprava kvinapril hidroklorida
EP1725527A4 (en) IMPROVED MANUFACTURE OF ATORVASTATIN
EP1666024A4 (en) PREPARATION FOR RECTAL ADMINISTRATION
IL165356A0 (en) Preparation of 4-haloalkylkylnicotinamides
GB0300455D0 (en) Meyhod of vaccine preparation
ZA200406777B (en) Production of abalone
TW553243U (en) Structure of clotheshanger
GB0409250D0 (en) Preparation of cabergoline
HU0300255D0 (en) Process for the preparation of 2-phenyl-4-methyl-1-tosil-piperazine
TW582219U (en) Improved structure of flabellum